MyFinsight
Home
Blog
About
Cash
$3,017,096
(125.46%↑ Y/Y)
Prepaid and other
current assets
$375,371
(-15.47%↓ Y/Y)
Property and equipment,
net
$11,235
(5574.24%↑ Y/Y)
Total current assets
$3,392,467
(90.34%↑ Y/Y)
Total non-current
assets
$11,235
(-91.12%↓ Y/Y)
Total assets
$3,403,702
(78.32%↑ Y/Y)
Total liabilities and
stockholders' equity...
$3,403,702
(78.32%↑ Y/Y)
Total liabilities
$3,103,090
(-71.04%↓ Y/Y)
Total stockholders'
equity (deficit)
$300,612
(103.41%↑ Y/Y)
Accumulated deficit
-$41,402,706
(-43.36%↓ Y/Y)
Total current
liabilities
$3,040,423
(-71.09%↓ Y/Y)
Warrant liability
$62,667
(-68.74%↓ Y/Y)
Additional paid-in capital
$41,697,721
(107.77%↑ Y/Y)
Common stock, 0.0001
par value...
$5,597
(115.19%↑ Y/Y)
Short-term debt, related
parties
$1,442,500
(0.00%↑ Y/Y)
Accounts payable and
accrued expenses
$655,089
(51.69%↑ Y/Y)
Deferred underwriting
fee payable
$500,000
(0.00%↑ Y/Y)
Accrued interest,
related parties
$241,403
(45.58%↑ Y/Y)
Due to related
parties
$201,431
(18.10%↑ Y/Y)
Back
Back
Balance Sheet
Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma, Inc. (LIMNW)
source: myfinsight.com